• Contact us
  • Customer support
  • Login
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
XVIVO
  • Contact us
  • Customer support
  • Home
  • Technology
    • Introduction to Ex Vivo Lung Perfusion
    • The Ex Vivo Lung Perfusion Process
    • Clinical
    • Protocols
    • Starting your clinical EVLP program
    • Articles about EVLP
    • EVLP with Manual method
    • EVLP with XPS™
    • Training and workshops
    • Patents
  • Products
    • Our Products
    • XPS™
    • XPS Disposable Lung Kit™
    • STEEN Solution™
    • PERFADEX® Plus
    • XVIVO
      Organ Chamber™
    • XVIVO
      Lung Cannula Set™
    • Instruction for Use
  • Knowledge
    • NOVEL Lung Trial
    • Literature
    • Insights
  • Media
    • Videos
    • Webinars
    • Establishing a successful EVLP program
  • About us
    • About XVIVO
    • History
    • Our market
    • News
    • Career
    • Working at XVIVO
  • Corporate
    • Corporate
    • The share
      • Info
      • Ownership structure
      • Insiders (PDMRs)
    • Press releases
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
    • Financial calendar
    • Financial reports
    • Financial reports – ESEF
    • Prospectus and material offerings
      • Material offerings
      • Prospectus
    • Financial presentations
      • Capital Markets Day
      • Earnings calls
    • Corporate governance
      • Article of Association
      • General meetings
      • Board of Directors
      • Senior Management
      • Auditors
      • Board Committees
      • Board and Senior Management share holdings
      • Guidelines for remuneration
      • Nomination Committee
      • Corporate Governance Reports
    • Analyst Coverage
    • Code of Conduct
    • Environmental Policy
    • Code of Conduct for Suppliers
    • Privacy policy
    • Contact us
    • Subscribe
    • Thank you
    • Error
  • Corporate
  • The share
    • Info
    • Ownership structure
    • Insiders (PDMRs)
  • Press releases
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
  • Financial calendar
  • Financial reports
  • Financial reports – ESEF
  • Prospectus and material offerings
    • Material offerings
    • Prospectus
  • Financial presentations
    • Capital Markets Day
    • Earnings calls
  • Corporate governance
    • Article of Association
    • General meetings
    • Board of Directors
    • Senior Management
    • Auditors
    • Board Committees
    • Board and Senior Management share holdings
    • Guidelines for remuneration
    • Nomination Committee
    • Corporate Governance Reports
  • Analyst Coverage
  • Code of Conduct
  • Environmental Policy
  • Code of Conduct for Suppliers
  • Privacy policy
  • Contact us
  • Subscribe
  • Thank you
  • Error

Press releases 2017

  • All press releases
  • Regulatory Press Releases
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2017-12-01 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Första XPS™ installerad i Kina
2017-12-01 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ installed in China
2017-11-07 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Reimbursement-koder erhållna för hela EVLP processen i USA
2017-11-07 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Reimbursement codes obtained for doctor´s time during EVLP procedure
2017-10-27 08:00
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion (publ) Interim Report January – September 2017
2017-10-27 08:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) delårsrapport januari – september 2017
2017-10-20 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-10-20 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-09-21 14:30
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2017-09-21 14:30
News
IR
English
Corporate Information
Nomination Committee
Nomination Committee of XVIVO Perfusion AB (publ)
2017-09-12 14:40
News
IR
Swedish
Corporate Information
Other Corporate Information
Första hjärttransplantationen med Stig Steens nya metod genomförd på människa
2017-09-12 14:40
News
IR
English
Corporate Information
Other Corporate Information
First clinical heart transplant performed using Stig Steen’s new method
2017-07-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO Perfusion´s CFO appointed Deputy CEO
2017-07-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO Perfusions CFO utnämnd till vice VD
2017-07-14 08:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
Interim Report January – June 2017
2017-07-14 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
Delårsrapport januari – juni 2017
2017-07-13 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
PrimECC studien färdigrekryterad
2017-07-13 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Recruitment completed for PrimECC study
2017-07-10 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-07-10 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-07-06 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Recruitment completed for NOVEL study in the US on STEEN Solution™ and XPS™
2017-07-06 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
NOVEL-studien i USA med STEEN Solution™ och XPS™ färdigrekryterad
2017-06-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2017-06-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2017-04-28 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2017-04-28 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2017-04-26 17:17
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2017-04-26 17:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2017-04-25 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Delårsrapport januari – mars 2017
2017-04-25 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Interim Report January – March 2017
2017-04-19 09:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2017-04-19 09:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2017-04-12 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ sold to Australia and to the Netherlands
2017-04-12 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Australien och Nederländerna nya länder med XPS™
2017-04-10 09:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
SUMMARY FROM EXTRAORDINARY GENERAL MEETING OF XVIVO PERFUSION AKTIEBOLAG (PUBL)
2017-04-10 09:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I XVIVO PERFUSION AKTIEBOLAG (PUBL)
2017-04-04 07:00
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2016
2017-04-04 07:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2016
2017-03-20 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2017-03-20 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2017-03-17 07:35
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice of Extraordinary General Meeting of XVIVO Perfusion Aktiebolag (publ)
2017-03-17 07:35
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion Aktiebolag (publ)
2017-03-17 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
Styrelsen för XVIVO Perfusion beslutar om nyemission om högst ca. 181 miljoner kronor riktad till institutionella investerare
2017-03-17 07:30
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
The board of directors of XVIVO Perfusion resolves upon an up to approx. SEK 181 million share issue directed to institutional investors
2017-03-16 18:45
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
XVIVO Perfusion avser att genomföra en riktad emission av aktier
2017-03-16 18:45
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
XVIVO Perfusion intends to undertake a private placement of shares
2017-02-08 08:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
XVIVO Perfusion Report on Operations 2016
2017-02-08 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
Bokslutskommuniké 2016
2017-02-03 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2017-02-03 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2017-12-01 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Första XPS™ installerad i Kina
2017-12-01 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
First XPS™ installed in China
2017-11-07 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Reimbursement-koder erhållna för hela EVLP processen i USA
2017-11-07 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Reimbursement codes obtained for doctor´s time during EVLP procedure
2017-10-27 08:00
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion (publ) Interim Report January – September 2017
2017-10-27 08:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion AB (publ) delårsrapport januari – september 2017
2017-07-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO Perfusion´s CFO appointed Deputy CEO
2017-07-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
XVIVO Perfusions CFO utnämnd till vice VD
2017-07-14 08:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
Interim Report January – June 2017
2017-07-14 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
Delårsrapport januari – juni 2017
2017-07-13 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
PrimECC studien färdigrekryterad
2017-07-13 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Recruitment completed for PrimECC study
2017-07-06 08:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Recruitment completed for NOVEL study in the US on STEEN Solution™ and XPS™
2017-07-06 08:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
NOVEL-studien i USA med STEEN Solution™ och XPS™ färdigrekryterad
2017-06-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2017-06-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2017-04-28 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Change in number of shares and votes in XVIVO Perfusion
2017-04-28 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Förändring av antalet aktier och röster i XVIVO Perfusion
2017-04-26 17:17
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2017-04-26 17:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
Next
About us

Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives.
Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine.
XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on three continents. The company is listed on Nasdaq.

Contact

Swedish Office
XVIVO Perfusion AB
Box 53015
SE-400 14 Göteborg
Sweden

Phone: +46 31 788 21 50
Fax: +46 31 788 21 69
info@xvivogroup.com

 

Report a violations or breach here: Whistleblower

  • Home
  • Technology
  • Products
  • Knowledge
  • Media
  • About us
  • Corporate

Copyright © 2023 XVIVO. All rights reserved.

Design mkmedia
To top

We use cookies to improve the user experience on XVIVO. Read more about Cookies

Approve